Lipid abnormalities in kidney disease and management strategies

doi:10.5527/wjn.v4.i1.83

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8328)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

661

WORD

279

HTML

4457

Tables (1-4)

181

Sum=5578

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1237

Download

1513

Sum=2750

Feb 6, 2015 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (39)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Nephrol. Feb 6, 2015; 4(1): 83-91
Published online Feb 6, 2015. doi: 10.5527/wjn.v4.i1.83

Table 3 Kidney diseases: improving global outcomes recommended doses of commonly used statins, based on doses used in trials, in patients with estimated glomerular filtration rate < 60[9,35,45-47]

	Dose (mg/d)
Fluvastatin	80
Atorvastatin	20
Rosuvastatin	10
Simvastatin/ezetimibe	20/10
Pravastatin	40
Simvastatin	40
Pitavastatin	2

Citation: Pandya V, Rao A, Chaudhary K. Lipid abnormalities in kidney disease and management strategies. World J Nephrol 2015; 4(1): 83-91
URL: https://www.wjgnet.com/2220-6124/full/v4/i1/83.htm
DOI: https://dx.doi.org/10.5527/wjn.v4.i1.83